Resveratrol-induced apoptosis in human breast cancer cells is mediated primarily through the caspase-3-dependent pathway

Resveratrol-induced apoptosis in human breast cancer cells is mediated primarily through the caspase-3-dependent pathway
复制标题

DOI:
10.1016/j.arcmed.2007.09.003
复制
发表时间:
2008-02-01
影响因子:
7.7
通讯作者:
Al-Attyiah, Rajaa
Al-Attyiah, Rajaa
中科院分区:
医学4区
文献类型:
--
作者:
Alkhalaf, Moussa;El-Mowafy, Abdulla;Al-Attyiah, Rajaa

文献摘要

被引文献

相似文献

背景白藜芦醇(RSVL)是一种无毒的天然化合物,广泛存在于各种植物中,具有抗氧化和抗炎作用,正成为一种有效的化学预防和抗癌药物。最近,我们证明了RSVL诱导的几种人癌细胞系的凋亡与促凋亡的116 kDa聚(ADP-核糖)聚合酶蛋白(PARP)裂解成其89 kDa片段有关。Western blotting检测caspase-3和PARP蛋白表达水平。用caspase-3比色底物DEVD-pNA分析caspase活性。Annexin V-FITC-propidium iodide双染法检测凋亡细胞。我们发现RSVL以剂量和时间依赖性方式将未成熟的caspase-3(35 kDa)切割成活性片段(p12,p17,p20)。此外,RSVL显著增加细胞中的caspase-3活性(5倍)。有趣的是,RSVL诱导的PARP裂解和凋亡可通过抑制caspase-3而特异性阻断。总的来说,这些数据表明RSVL激活caspase-3是MDA-MB-231细胞中PARP降解和诱导细胞凋亡所必需的,并为RSVL的作用提供了额外的见解,从而证实了RSVL对人乳腺癌的化学预防潜力。(C)2008年IMSS。爱思唯尔公司出版
Background. Resveratrol (RSVL), a nontoxic natural compound found in a wide variety of plants with known antioxidant and anti-inflammatory properties, is emerging as a potent chemopreventive and anticancer drug. Recently, we demonstrated that RSVL-induced apoptosis in several human cancer cell lines was associated with cleavage of the proapoptotic 116 kDa poly(ADP-ribose) polymerase protein (PARP) into its 89-kDa fragment.Methods. Western blotting was used to check the levels of caspase-3 and PARP proteins. The caspase activity was analyzed with the caspase-3 colorimetric substrate DEVD-pNA. Apoptotic cells were quantified by annexin V-FITC-propidium iodide double staining.Results. We show that RSVL cleaved the immature caspase-3 (35 kDa) into the active fragments (p12, p17, p20) in a dose- and time-dependent manner. In addition, RSVL markedly increased caspase-3 activity (5-fold) in cells. Interestingly, RSVL-induced PARP cleavage and apoptosis was blocked specifically by inhibiting caspase-3.Conclusions. Collectively, the data suggest that caspase-3 activation by RSVL is required for PARP degradation and induction of apoptosis in MDA-MB-231 cells and provide additional insights into the action of RSVL, thus substantiating the chemopreventive potential of RSVL against human breast cancer. (C) 2008 IMSS. Published by Elsevier Inc.